Literature DB >> 22609873

Protective mechanism of nicorandil on rat myocardial ischemia-reperfusion.

Ailing Wang1, Feng Chen, Yangjing Xie, Zeng Guo, Yuanxun Yu.   

Abstract

OBJECTIVES: To study the protective mechanism of nicorandil on myocardial ischemia-reperfusion injury.
METHODS: Fifty rats were randomly divided into five groups, four of which were operated on to produce myocardial ischemia-reperfusion. Nicorandil (5 mg/kg) was administrated by intravenous injection to three of the groups. The myocardial ultrastructure was observed by electron microscope. The expression levels of the antiapoptotic protein Bcl-2 and the pro-apoptotic protein Bax were detected by immunohistochemical staining with rhodamine 123. The mitochondrial membrane potential was detected by spectrophotometry.
RESULTS: The activity of lactate dehydrogenase (LDH) and malondialdehyde (MDA) content was decreased and the activity of superoxide dismutase (SOD) was increased in the three nicorandil groups, compared with those in the group without nicorandil (P < 0.01, P < 0.05). The positive staining level of the expressed Bcl-2 was increased and the expressed Bax was decreased (P < 0.01) in the three nicorandil groups, compared with those in the group without nicorandil. The mitochondrial inner membrane potential was increased in the three nicorandil groups compared with that in the group without nicorandil (P < 0.05).
CONCLUSION: A suitable level of nicorandil has a protective effect on rats' myocardial ischemia-reperfusion injury, and is mainly based on the opening of the mitochondrial KATP channel and the lowing of Ca overload.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609873     DOI: 10.2459/JCM.0b013e3283542031

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  8 in total

1.  Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial.

Authors:  Chunhong Chen; Xianghua Fu; Wei Li; Xinwei Jia; Shiru Bai; Wei Geng; Kun Xing
Journal:  Exp Ther Med       Date:  2015-07-07       Impact factor: 2.447

2.  Pharmacological preconditioning and postconditioning with nicorandil attenuates ischemia/reperfusion-induced myocardial necrosis and apoptosis in hypercholesterolemic rats.

Authors:  Wenna Li; Nan Wu; Wenqi Shu; Dalin Jia; Pengyu Jia
Journal:  Exp Ther Med       Date:  2015-10-01       Impact factor: 2.447

3.  Effect of sequential nicorandil on myocardial microcirculation and short-term prognosis in acute myocardial infarction patients undergoing coronary intervention.

Authors:  Shu-Fang Pi; Ying-Wu Liu; Tong Li; Yu Wang; Quan Zhou; Bo-Jiang Liu; Wen-Jin Peng; Xin Li; Yun-Yun Wang; Lei Huang
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

4.  Effect of Intravenous Administration of Liposomal Prostaglandin E1 on Microcirculation in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention.

Authors:  Li-Ye Wei; Xiang-Hua Fu; Wei Li; Xi-Le Bi; Shi-Ru Bai; Kun Xing; Yan-Bo Wang
Journal:  Chin Med J (Engl)       Date:  2015-05-05       Impact factor: 2.628

Review 5.  Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.

Authors:  Xiaowei Niu; Jingjing Zhang; Ming Bai; Yu Peng; Shaobo Sun; Zheng Zhang
Journal:  BMC Cardiovasc Disord       Date:  2018-01-10       Impact factor: 2.298

6.  Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention.

Authors:  Xiao-Tao Zhao; Chun-Fei Zhang; Qing-Jie Liu
Journal:  BMC Cardiovasc Disord       Date:  2019-06-14       Impact factor: 2.298

7.  Nicorandil inhibits cardiomyocyte apoptosis and improves cardiac function by suppressing the HtrA2/XIAP/PARP signaling after coronary microembolization in rats.

Authors:  Jing Zheng; Manyun Long; Zhenbai Qin; Fen Wang; Zhiqing Chen; Lang Li
Journal:  Pharmacol Res Perspect       Date:  2021-02

8.  Combined Systemic Intake of K-ATP Opener (Nicorandil) and Mesenchymal Stem Cells Preconditioned With Nicorandil Alleviates Pancreatic Insufficiency in a Model of Bilateral Renal Ischemia/Reperfusion Injury.

Authors:  Asmaa Mohammed ShamsEldeen; Sarah A Abd El-Aal; Basma Emad Aboulhoda; Hend AbdAllah; Sara Mahmoud Gamal; Fatma E Hassan; Marwa Nagi Mehesen; Laila Ahmed Rashed; Abeer Mostafa; Nermeen Bakr Sadek
Journal:  Front Physiol       Date:  2022-06-23       Impact factor: 4.755

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.